Tech Company Financing Transactions
RhinoCyte Funding Round
RhinoCyte, operating out of Louisville, raised $550 thousand from Kentucky Seed Capital Fund.
Transaction Overview
Company Name
Announced On
9/30/2014
Transaction Type
Venture Equity
Amount
$550,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
201 East Jefferson St. 135
Louisville, KY 40202
USA
Louisville, KY 40202
USA
Phone
Website
Email Address
Overview
RhinoCyte Inc. is a biopharmaceutical company focused on developing innovative treatments using stem cells taken from the nose lining of adults. The company's goal is to extend and enhance patients' quality of life through regenerative medicine treatments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Fred Roisen
Co-Founder
Steve Gailar
Browse more venture capital transactions:
Prev: 9/30/2014: Synup venture capital transaction
Next: 9/30/2014: Five Star Technologies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs